Santen Pharmaceutical Logo

Santen Pharmaceutical

🇯🇵
4536
JP3336000009

Santen Pharmaceutical is a leading Japanese pharmaceutical company specializing in ophthalmology. It researches, develops, manufactures, and distributes innovative medications and therapies to improve eye health globally. The company is dedicated to patients with eye diseases and to promoting vision.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Santen Pharmaceutical report its next quarterly earnings?

Santen Pharmaceutical is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Santen Pharmaceutical last report quarterly earnings?

Santen Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 22.38 JPY.

How does Santen Pharmaceutical stock react to earnings?

Across its last 5 earnings reports, Santen Pharmaceutical stock moved by ±1.9% on average the following day. The largest reaction was -3.7% on 05/12/2026; 2 of 5 reactions were positive.

How often has Santen Pharmaceutical beaten expectations?

Santen Pharmaceutical has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Santen Pharmaceutical earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:¥29.10
Actual:
Q2 2026
Beat
Estimate:¥21.30
Actual:¥22.38
Difference:+¥1.08
Price reaction (1 day):+1.1 %
Q1 2026
Beat
Estimate:¥30.79
Actual:¥47.88
Difference:+¥17.09
Price reaction (1 day):-3.7 %
Price reaction (7 days):+16.7 %
Q4 2025
Missed
Estimate:¥27.89
Actual:¥24.40
Difference:-¥3.49
Price reaction (1 day):+0.9 %
Price reaction (7 days):-2.3 %
Q3 2025
Beat
Estimate:$20.90
Actual:$24.44
Difference:+$3.54
Price reaction (1 day):-0.3 %
Price reaction (7 days):+0.3 %
Q1 2025
Missed
Estimate:$23.90
Actual:$17.32
Difference:-$6.58
Q4 2024
Estimate:
Actual:
Price reaction (1 day):-3.5 %
Price reaction (7 days):-7.9 %

Earnings statistics

Stock reaction to earnings

±1.9%
Avg. next-day move
-3.7%
Largest move (05/12/2026)
40%
Share of positive reactions
±6.8%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+9.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Santen Pharmaceutical
Ticker Symbol
4536
ISIN
JP3336000009
Country
🇯🇵
Japan
Sector